Some parts of Medicare, including Part B and Part D, may cover the approved drug Humira (adalimumab ... or use of any insurance or insurance products. Healthline Media does not transact the ...

CVS Health has said it will remove AbbVie’s big-selling immunology drug Humira from most of its national formulary lists of reimbursable products, and offer biosimilar versions of the drug instead.

EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...

Yesterday, Amgen announced that it would launch the U.S.’s first marketed Humira-referenced biosimilar ... market share towards a “preferred” product. To date, several of the large PBMs ...